Coya Therapeutics (COYA) Revenue & Revenue Breakdown
Coya Therapeutics Revenue Highlights
Latest Revenue (Y)
$6.00M
Latest Revenue (Q)
$3.43M
Coya Therapeutics Revenue by Period
Coya Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $6.00M | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | - |
Coya Therapeutics generated $6.00M in revenue during NA 2023, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Coya Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $3.43M | 2600.51% |
| 2024-03-31 | $126.84K | -97.89% |
| 2023-12-31 | $6.00M | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | - |
Coya Therapeutics generated $3.43M in revenue during Q2 2024, up 2600.51% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Coya Therapeutics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| STRO | Sutro Biopharma | $153.73M | $13.01M |
| FENC | Fennec Pharmaceuticals | $21.64M | $25.26M |
| TCRX | TScan Therapeutics | $21.05M | - |
| CNTA | Centessa Pharmaceuticals | $6.88M | - |
| COYA | Coya Therapeutics | $6.00M | $3.43M |
| CUE | Cue Biopharma | $5.49M | $1.72M |
| TFFP | TFF Pharmaceuticals | $733.87K | $650.22K |
| LIFE | aTyr Pharma | $353.00K | $235.00K |
| OPT | Opthea | $108.41K | $61.27K |
| GANX | Gain Therapeutics | $55.18K | - |
| DAWN | Day One Biopharmaceuticals | - | $8.19M |
| ABOS | Acumen Pharmaceuticals | - | - |
| INZY | Inozyme Pharma | - | - |
| GRTX | Galera Therapeutics | - | - |
| INAB | IN8bio | - | - |
| CGTX | Cognition Therapeutics | - | - |
| ELYM | Eliem Therapeutics | - | - |
| TERN | Terns Pharmaceuticals | - | - |
| DRMA | Dermata Therapeutics | - | - |
| HLVX | HilleVax | - | - |
| LTRN | Lantern Pharma | - | - |
COYA Revenue FAQ
What is Coya Therapeutics’s yearly revenue?
Coya Therapeutics's yearly revenue for 2023 was $6M, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. COYA's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.
What is Coya Therapeutics’s quarterly revenue?
Coya Therapeutics's quarterly revenue for Q2 2024 was $3.43M, a 2600.51% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $126.84K, a -97.89% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). COYA's quarterly revenue for Q4 2023 was $6M, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022).
What is Coya Therapeutics’s revenue growth rate?
Coya Therapeutics's revenue growth rate for the last 3 years (2021-2023) was 0%